Huntsworth plc (LON:HNT)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $93.32 and traded as low as $91.00. Huntsworth shares last traded at $91.00, with a volume of 70,496 shares traded.

Several equities analysts have weighed in on the company. Numis Securities reissued a “buy” rating on shares of Huntsworth in a research report on Tuesday, May 21st. Berenberg Bank upped their price objective on Huntsworth from GBX 120 ($1.57) to GBX 125 ($1.63) and gave the company a “buy” rating in a research report on Thursday, May 23rd. Peel Hunt reaffirmed a “buy” rating on shares of Huntsworth in a research note on Wednesday, September 4th. Finally, Peel Hunt reaffirmed a “buy” rating and set a GBX 135 ($1.76) price objective on shares of Huntsworth in a research note on Wednesday, July 3rd.

The company has a market capitalization of $336.01 million and a price-to-earnings ratio of 28.44. The company has a current ratio of 1.19, a quick ratio of 1.10 and a debt-to-equity ratio of 73.94. The company’s 50 day simple moving average is GBX 95.52 and its 200-day simple moving average is GBX 93.27.

The company also recently disclosed a dividend, which will be paid on Wednesday, November 6th. Stockholders of record on Thursday, September 26th will be given a GBX 0.75 ($0.01) dividend. This represents a dividend yield of 0.84%. The ex-dividend date is Thursday, September 26th. Huntsworth’s dividend payout ratio is presently 0.63%.

In other Huntsworth news, insider Paul Taaffe sold 533,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of GBX 102 ($1.33), for a total value of £543,660 ($710,388.08). Also, insider Neil Jones sold 45,100 shares of Huntsworth stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of GBX 99 ($1.29), for a total value of £44,649 ($58,341.83).

Huntsworth Company Profile (LON:HNT)

Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams.

Featured Article: Conference Calls

Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.